Compass Therapeutics (CMPX) Current Assets: 2023-2025
Historic Current Assets for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $221.1 million.
- Compass Therapeutics' Current Assets rose 56.67% to $221.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $221.1 million, marking a year-over-year increase of 56.67%. This contributed to the annual value of $132.8 million for FY2024, which is 13.73% down from last year.
- As of Q3 2025, Compass Therapeutics' Current Assets stood at $221.1 million, which was up 108.22% from $106.2 million recorded in Q2 2025.
- In the past 5 years, Compass Therapeutics' Current Assets registered a high of $221.1 million during Q3 2025, and its lowest value of $106.2 million during Q2 2025.
- Its 3-year average for Current Assets is $156.1 million, with a median of $153.9 million in 2023.
- Data for Compass Therapeutics' Current Assets shows a peak YoY increase of 56.67% (in 2025) and a maximum YoY decrease of 30.84% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Compass Therapeutics' Current Assets stood at $153.9 million in 2023, then decreased by 13.73% to $132.8 million in 2024, then skyrocketed by 56.67% to $221.1 million in 2025.
- Its Current Assets was $221.1 million in Q3 2025, compared to $106.2 million in Q2 2025 and $124.1 million in Q1 2025.